From The Economic Times · ET Bureau · · 1m 10s
FSSAI Pulls Dr Reddy's and Nestle Health Science
Food safety regulator FSSAI orders Dr Reddy's and Nestle Health Science to stop misleading claims about Celevida GLP+ nutrition product.
In brief
Food safety regulator FSSAI orders Dr Reddy's and Nestle Health Science to stop misleading claims about Celevida GLP+ nutrition product. FSSAI has directed Dr Reddy's and Nestle Health Science to stop using terms like '100%' and health claims for Celevida GLP+ after finding it misleading for weight-loss treatments…
FSSAI Issues Notices
Food safety regulator FSSAI has issued notices to Dr Reddy's and Nestle Health Science, Flipkart, Amazon and three other entities over allegedly misleading advertising and health claims for Celevida GLP+.
Misleading Health Claims
FSSAI said the product was advertised as providing high-protein support for preserving lean muscle during GLP-1/GIP therapies, commonly used in weight-loss treatment.
Specific Claims Flagged
FSSAI found claims like 'helps maintain lean muscle', 'support muscle strength' and 'preserve lean mass' suggested the product could prevent muscle loss during weight reduction and glp-1/gip therapy.
Action Required
FSSAI has directed food businesses to discontinue use of term '100%' on food labels and show cause why action should not be initiated under the Food Safety and Standards Act, 2006.
What it means
FSSAI has directed Dr Reddy's and Nestle Health Science to stop using terms like '100%' and health claims for Celevida GLP+ after finding it misleading for weight-loss treatments.